Amoy Diagnostics Co Ltd
SZSE:300685

Watchlist Manager
Amoy Diagnostics Co Ltd Logo
Amoy Diagnostics Co Ltd
SZSE:300685
Watchlist
Price: 24.8 CNY -4.62% Market Closed
Market Cap: 9.7B CNY
Have any thoughts about
Amoy Diagnostics Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Amoy Diagnostics Co Ltd stock under the Base Case scenario is 28 CNY. Compared to the current market price of 24.8 CNY, Amoy Diagnostics Co Ltd is Undervalued by 11%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
28 CNY
Undervaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Amoy Diagnostics Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Amoy Diagnostics Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Amoy Diagnostics Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Amoy Diagnostics Co Ltd

Provide an overview of the primary business activities
of Amoy Diagnostics Co Ltd.

What unique competitive advantages
does Amoy Diagnostics Co Ltd hold over its rivals?

What risks and challenges
does Amoy Diagnostics Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Amoy Diagnostics Co Ltd.

Provide P/S
for Amoy Diagnostics Co Ltd.

Provide P/E
for Amoy Diagnostics Co Ltd.

Provide P/OCF
for Amoy Diagnostics Co Ltd.

Provide P/FCFE
for Amoy Diagnostics Co Ltd.

Provide P/B
for Amoy Diagnostics Co Ltd.

Provide EV/S
for Amoy Diagnostics Co Ltd.

Provide EV/GP
for Amoy Diagnostics Co Ltd.

Provide EV/EBITDA
for Amoy Diagnostics Co Ltd.

Provide EV/EBIT
for Amoy Diagnostics Co Ltd.

Provide EV/OCF
for Amoy Diagnostics Co Ltd.

Provide EV/FCFF
for Amoy Diagnostics Co Ltd.

Provide EV/IC
for Amoy Diagnostics Co Ltd.

Show me price targets
for Amoy Diagnostics Co Ltd made by professional analysts.

What are the Revenue projections
for Amoy Diagnostics Co Ltd?

How accurate were the past Revenue estimates
for Amoy Diagnostics Co Ltd?

What are the Net Income projections
for Amoy Diagnostics Co Ltd?

How accurate were the past Net Income estimates
for Amoy Diagnostics Co Ltd?

What are the EPS projections
for Amoy Diagnostics Co Ltd?

How accurate were the past EPS estimates
for Amoy Diagnostics Co Ltd?

What are the EBIT projections
for Amoy Diagnostics Co Ltd?

How accurate were the past EBIT estimates
for Amoy Diagnostics Co Ltd?

Compare the revenue forecasts
for Amoy Diagnostics Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Amoy Diagnostics Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Amoy Diagnostics Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Amoy Diagnostics Co Ltd compared to its peers.

Compare the P/E ratios
of Amoy Diagnostics Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Amoy Diagnostics Co Ltd with its peers.

Analyze the financial leverage
of Amoy Diagnostics Co Ltd compared to its main competitors.

Show all profitability ratios
for Amoy Diagnostics Co Ltd.

Provide ROE
for Amoy Diagnostics Co Ltd.

Provide ROA
for Amoy Diagnostics Co Ltd.

Provide ROIC
for Amoy Diagnostics Co Ltd.

Provide ROCE
for Amoy Diagnostics Co Ltd.

Provide Gross Margin
for Amoy Diagnostics Co Ltd.

Provide Operating Margin
for Amoy Diagnostics Co Ltd.

Provide Net Margin
for Amoy Diagnostics Co Ltd.

Provide FCF Margin
for Amoy Diagnostics Co Ltd.

Show all solvency ratios
for Amoy Diagnostics Co Ltd.

Provide D/E Ratio
for Amoy Diagnostics Co Ltd.

Provide D/A Ratio
for Amoy Diagnostics Co Ltd.

Provide Interest Coverage Ratio
for Amoy Diagnostics Co Ltd.

Provide Altman Z-Score Ratio
for Amoy Diagnostics Co Ltd.

Provide Quick Ratio
for Amoy Diagnostics Co Ltd.

Provide Current Ratio
for Amoy Diagnostics Co Ltd.

Provide Cash Ratio
for Amoy Diagnostics Co Ltd.

What is the historical Revenue growth
over the last 5 years for Amoy Diagnostics Co Ltd?

What is the historical Net Income growth
over the last 5 years for Amoy Diagnostics Co Ltd?

What is the current Free Cash Flow
of Amoy Diagnostics Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Amoy Diagnostics Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amoy Diagnostics Co Ltd

Current Assets 1.7B
Cash & Short-Term Investments 1.1B
Receivables 591.8m
Other Current Assets 43.5m
Non-Current Assets 296.4m
Long-Term Investments 22.4m
PP&E 189.3m
Intangibles 47.1m
Other Non-Current Assets 37.6m
Current Liabilities 212m
Accounts Payable 17.7m
Accrued Liabilities 64.4m
Short-Term Debt 6.1m
Other Current Liabilities 123.9m
Non-Current Liabilities 12.6m
Long-Term Debt 3.7m
Other Non-Current Liabilities 8.8m
Efficiency

Earnings Waterfall
Amoy Diagnostics Co Ltd

Revenue
1.2B CNY
Cost of Revenue
-186.1m CNY
Gross Profit
997.8m CNY
Operating Expenses
-659.6m CNY
Operating Income
338.2m CNY
Other Expenses
-23.2m CNY
Net Income
315m CNY

Free Cash Flow Analysis
Amoy Diagnostics Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Amoy Diagnostics Co Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Exceptional ROIC
69/100
Profitability
Score

Amoy Diagnostics Co Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Amoy Diagnostics Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Amoy Diagnostics Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Amoy Diagnostics Co Ltd

Wall Street analysts forecast Amoy Diagnostics Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Amoy Diagnostics Co Ltd is 30.85 CNY with a low forecast of 24.08 CNY and a high forecast of 37.8 CNY.

Lowest
Price Target
24.08 CNY
3% Downside
Average
Price Target
30.85 CNY
24% Upside
Highest
Price Target
37.8 CNY
52% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Amoy Diagnostics Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Amoy Diagnostics Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Amoy Diagnostics Co Ltd Logo
Amoy Diagnostics Co Ltd

Country

China

Industry

Biotechnology

Market Cap

9.9B CNY

Dividend Yield

0.6%

Description

Amoy Diagnostics Co., Ltd. engages in the research, development, production and sale of tumour precision medical molecular diagnostic products. The company is headquartered in Xiamen, Fujian and currently employs 1,096 full-time employees. The company went IPO on 2017-08-02. The firm provides testing reagents and testing services for tumor diagnosis. The Company’s testing reagent products include ADx-ARMS product line for tumor tissue specimen detection, Super-ARMS product line for liquid biopsy, the NGS product line and the FISH product line. The products are used for the detection of non-small cell lung cancer, colorectal cancer, thyroid cancer, melanoma and other malignant tumors. The firm also provides data software to capture and analyze gene sequencing data. The firm provides testing services through its own medical testing institutions, including lung cancer testing, colorectal cancer testing and breast cancer testing.

Contact

FUJIAN
Xiamen
No.39, Dingshan Road, Haicang District
+865926806830
www.amoydx.com

IPO

2017-08-02

Employees

1 096

Officers

CFO, Accounting Supervisor & Secretary to the Board of Directors
Ms. Ying Chen
Deputy GM, CTO & Director
Mr. Ruan Li
Deputy General Manager
Mr. Huibin Zheng
GM & Director
Mr. Jiemin Luo
Deputy GM & Director
Ms. Fei Luo

See Also

Discover More
What is the Intrinsic Value of one Amoy Diagnostics Co Ltd stock?

The intrinsic value of one Amoy Diagnostics Co Ltd stock under the Base Case scenario is 28 CNY.

Is Amoy Diagnostics Co Ltd stock undervalued or overvalued?

Compared to the current market price of 24.8 CNY, Amoy Diagnostics Co Ltd is Undervalued by 11%.

Back to Top